BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1850351)

  • 1. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Lugnier C; Desbuquois B; Benelli C
    Arch Biochem Biophys; 2001 Mar; 387(1):154-62. PubMed ID: 11368177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute in vivo stimulation of low-Km cyclic AMP phosphodiesterase activity by insulin in rat-liver Golgi fractions.
    Benelli C; Desbuquois B; De Gallé B
    Eur J Biochem; 1986 Apr; 156(1):211-20. PubMed ID: 3007144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.
    Geoffroy V; Fouque F; Nivet V; Clot JP; Lugnier C; Desbuquois B; Benelli C
    Eur J Biochem; 1999 Feb; 259(3):892-900. PubMed ID: 10092879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thyroidectomy, insulin, and phospholipids on cyclic AMP phosphodiesterase in rat adipocyte plasma membranes.
    Correze C; Thibout H
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):167-78. PubMed ID: 2987321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
    Degerman E; Belfrage P; Newman AH; Rice KC; Manganiello VC
    J Biol Chem; 1987 Apr; 262(12):5797-807. PubMed ID: 3032944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thyroid status on membrane-bound low Km cyclic nucleotide phosphodiesterase activities in rat adipocytes.
    Goswami A; Rosenberg IN
    J Biol Chem; 1985 Jan; 260(1):82-5. PubMed ID: 2981228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
    Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
    Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
    Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
    Iwase K
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by thyroid status of hepatic low Km phosphodiesterase.
    Morgan DW; Shaheen O; Keyes WG; Heimberg M
    Endocrinology; 1982 Jan; 110(1):260-4. PubMed ID: 6274622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-cycle-specific activity of cyclic nucleotide phosphodiesterase in Physarum polycephalum.
    Kupetz IS; Jeter JR
    Cell Tissue Kinet; 1985 Mar; 18(2):159-68. PubMed ID: 2982493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.